Paola Valenti

Varese, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Computer-aided image analysis for PD-L1 assessment in canine urothelial carcinoma.

Computer-aided image analysis for PD-L1 assessment in canine urothelial carcinoma.

Journal: Veterinary journal (London, England : 1997)

Published: February 08, 2026

Reply to In response to "Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study".

Reply to In response to "Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study".

Journal: The Journal of small animal practice

Published: October 10, 2025

Frequency, distribution, and prognostic impact of metastatic site in dogs with splenic hemangiosarcoma.

Frequency, distribution, and prognostic impact of metastatic site in dogs with splenic hemangiosarcoma.

Journal: Journal of veterinary internal medicine

Published: June 07, 2025

Tumor immune microenvironment and immune phenotypes in PD-L1-tested canine urothelial carcinoma.

Tumor immune microenvironment and immune phenotypes in PD-L1-tested canine urothelial carcinoma.

Journal: BMC veterinary research

Published: May 12, 2025

Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours.

Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours.

Journal: Veterinary and comparative oncology

Published: February 18, 2025

Retrospective Safety Evaluation of Combined Chlorambucil and Toceranib for the Treatment of Different Solid Tumours in Dogs.

Retrospective Safety Evaluation of Combined Chlorambucil and Toceranib for the Treatment of Different Solid Tumours in Dogs.

Journal: Animals : an open access journal from MDPI

Published: October 18, 2024

Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study.

Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study.

Journal: The Journal of small animal practice

Published: August 05, 2024

Evaluation of lung lobectomy and adjuvant treatment for primary pulmonary carcinoma in dogs: 89 cases (2005-2022).

Evaluation of lung lobectomy and adjuvant treatment for primary pulmonary carcinoma in dogs: 89 cases (2005-2022).

Journal: The Journal of small animal practice

Published: June 15, 2024

Comparison of CHOP-19 and CHOP-25 for treatment of peripheral nodal B-cell lymphoma in dogs: A European multicenter retrospective cohort study.

Comparison of CHOP-19 and CHOP-25 for treatment of peripheral nodal B-cell lymphoma in dogs: A European multicenter retrospective cohort study.

Journal: Journal of veterinary internal medicine

Published: May 29, 2024

Flow cytometry of non-hematopoietic cells in canine effusions.

Flow cytometry of non-hematopoietic cells in canine effusions.

Journal: Frontiers in veterinary science

Published: April 08, 2024

Use of Lomustine and Prednisolone as First-Line Treatment in Canine Multicentric Lymphoma.

Use of Lomustine and Prednisolone as First-Line Treatment in Canine Multicentric Lymphoma.

Journal: Veterinary and comparative oncology

Published: February 06, 2024

Prognostic impact of Ki-67 in canine splenic hemangiosarcoma: A preliminary study.

Prognostic impact of Ki-67 in canine splenic hemangiosarcoma: A preliminary study.

Journal: Veterinary pathology

Published: January 12, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026